Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H50N4O6S |
| Molecular Weight | 630.838 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3CCCCC3)[C@@H](O)[C@@H](O)C4CC4
InChI
InChIKey=UXIGZRQVLGFTOU-VQXQMPIVSA-N
InChI=1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1
| Molecular Formula | C33H50N4O6S |
| Molecular Weight | 630.838 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P00797 Gene ID: 5972.0 Gene Symbol: REN Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8498974 |
0.7 nM [IC50] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. | 2009 |
|
| Purification and characterization of recombinant human renin for X-ray crystallization studies. | 2008-06-26 |
|
| Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors. | 2008-05 |
|
| Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. | 2008 |
|
| The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. | 2008 |
|
| Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension. | 2007 |
|
| Functional expression of the renin-angiotensin system in human podocytes. | 2006-03 |
|
| Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats. | 2005-02 |
|
| Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules. | 2004-08 |
|
| Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. | 2004-03-08 |
|
| Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer. | 2003-02 |
|
| The power of visual imagery in synthesis planning. Stereocontrolled approaches to CGP-60536B, a potent renin inhibitor. | 2002-06-14 |
|
| Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals. | 1996-03 |
|
| Discovery of remikiren as the first orally active renin inhibitor. | 1993-02 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8783774
Patients with essential hypertension: 600 mg orally for 8 days
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:07 GMT 2025
by
admin
on
Mon Mar 31 18:17:07 GMT 2025
|
| Record UNII |
LC7FBL96A4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C783
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
||
|
WHO-VATC |
QC09XA01
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
||
|
WHO-ATC |
C09XA01
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
||
|
NCI_THESAURUS |
C270
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6324659
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
LC7FBL96A4
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
100000080825
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
FF-2
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
DB00212
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
DTXSID60155121
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
8803
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
6876
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
SUB10273MIG
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
C73099
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
REMIKIREN
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL31601
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
126222-34-2
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
4696
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|